SelectQuote delivered strong Q2 results driven by effective agent productivity and a successful Medicare Advantage season, despite adjusting fiscal 2026 guidance due to external pressures.

• Achieved senior EBITDA margins of 39%, near-record levels, on 4% policy volume growth.
• Health care services segment revenues grew 26% year-over-year, validating SelectRx's clinical value.
• Entered a strategic multi-year agreement with a key pharmacy benefit manager, enhancing reimbursement visibility.
• Announced a new $415 million credit facility, improving capital flexibility for growth initiatives.
• Adjusted fiscal 2026 guidance downwards by approximately $40 million due to changes in a key carrier's marketing budget.